Attune Neurosciences, Inc.

About

Attune Neurosciences, Inc. is a clinical-stage medical device company focused on enhancing human health and performance. The company develops non-invasive, clinically-proven products aimed at addressing various psychiatric and neurological conditions. Utilizing low-intensity focused ultrasound (LIFU) technology, Attune targets specific brain activity to treat deep brain structures associated with these conditions. The company is dedicated to improving health outcomes through advanced technologies and is supported by funding from notable venture capital investors and government agencies, including the National Institutes of Health and the U.S. Air Force. Attune is developing wearable solutions, such as a head-worn device for use during sleep, to improve comfort and usability. Attune's investigational products target a range of conditions, including sleep disorders, depression, chronic pain, movement disorders like Parkinson's disease, and tinnitus. The company is actively conducting clinical trials to validate the safety and efficacy of its technology, positioning itself as a key player in the growing neuromodulation devices market.